| propiconazole (Ref: CGA 64250) |
![]() |
Environmental Fate - Ecotoxicology - Human Health - A to Z Index - Home
Description: A fungicide with a broad range of activity including diseases caused by Cochliobolus sativus, Erysiphe graminis and Leptosphaeria nodorum
Introduction: 1980
EC Directive 1107/2009 (repealing 91/414):
| Status | Annex 1 |
| Dossier rapporteur/co-rapporteur | Finland |
| Date inclusion expires | 31/05/2014 |
Approved for use (
) or known to be used (
) in the following European countries:
AT |
BE |
BG |
CY |
CZ |
DE |
DK |
EE |
EL |
ES |
FI |
FR |
HU |
IE |
IT |
LT |
LU |
LV |
MT |
NL |
PL |
PT |
RO |
SE |
SI |
SK |
UK |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Also registered in: Australia, USA
| Pesticide type | Fungicide | |||
| Substance group | Triazole | |||
| Substance origin | Synthetic | |||
| Mode of action | Systemic with curative and protective action, works via the demethylation of C-14 during ergosterol biosynthesis | |||
| CAS RN | 60207-90-1 | |||
| EC number | 262-104-4 | |||
| CIPAC number | 408 | |||
| US EPA chemical code | 122101 | |||
| Chiral molecule | Yes | |||
| Chemical formula | C15H17Cl2N3O2 | |||
| SMILES | Clc1ccc(c(Cl)c1)C2(OCC(O2)CCC)Cn3ncnc3 | |||
| International Chemical Identifier (InChI) | InChI=1/C15H17Cl2N3O2/c1-2-3-12-7-21-15(22-12,8-20-10-18-9-19-20)13-5-4-11(16)6-14(13)17/h4-6,9-10,12H,2-3,7-8H2,1H3 | |||
| Structure diagram/image available? | Yes | |||
| Molecular mass (g mol-1) | 342.22 | |||
| IUPAC Name | (2RS,4RS;2RS,4SR)-1-[2-(2,4-dichlorophenyl)-4-propyl-1,3-dioxolan-2-ylmethyl]-1H-1,2,4-triazole | |||
| CAS Name | 1-[[2-(2,4-dichlorophenyl)-4-propyl-1,3-dioxolan-2-yl]methyl]-1H-1,2,4-triazole | |||
| Other status information | - | |||
| Herbicide Resistance Classification (HRAC) | Not applicable | |||
| Insecticide Resistance Classification (IRAC) | Not applicable | |||
| Fungicide Resistance Classification (FRAC) | 3 | |||
| Physical state | Yellow viscous liquid | |||
| Related substances & organisms | ||||
Formulations:
Degradation:
Key metabolites:
| Metabolite | Formation Medium | Estimated Maximum Occurrence Fraction | 91/414 Relevancy ![]() |
|
1,2,4-triazole (Ref: CGA 71019) ![]() |
Soil | 0.430 | Major fraction, Relevant | |
3-(2-((1H-1,2,4-triazol-1-yl)methyl)-2-(2,4-dichlorophenyl)-1,3-dioxolan-4-yl)propan-1-ol (Ref: CGA 118245) ![]() |
Soil | 0.230 | Major fraction, Relevant | |
Other known metabolites:
| Metabolite name and reference | Aliases | Formation Medium / Rate | Estimated Maximum Occurrence Fraction | Metabolising Enzymes |
| - | triazolyl acetic acid | Plant | - | - |
| 2-amino-3-(1H-1,2,4-triazol-1-yl)propanoic acid (Ref: CGA 131013) Note: Cas no; 86362-20-1 |
triazole alanine | Plant | - | - |
General:
Property ![]() |
Value | Source/Quality Score/Other Information ![]() |
Interpretation ![]() |
|
| Mammals - Acute oral LD50 (mg kg-1) | 958 | P4 Rat | Moderate | |
| Mammals - Dermal LD50 (mg kg-1 body weight) | > 4000 | A5 Rat | - | |
| Mammals - Inhalation LC50 (mg l-1) | 5.8 | A5 Rat (nose only) | - | |
| Other Mammal toxicity endpoints | - | - | ||
| ADI - Acceptable Daily Intake (mg kg-1bw day-1) | 0.04 | A5 Rat, SF=100 | - | |
| ARfD - Acute Reference Dose (mg kg-1bw day-1) | 0.3 | A5 Rat, SF=100 | - | |
| AOEL - Acceptable Operator Exposure Level - Systemic (mg kg-1bw day-1) | 0.1 | A5 Rat, SF=100 | - | |
| Dermal penetration studies (%) | 0.9-2.4 | A5 concentration dependant | - | |
| Dangerous Substances Directive 76/464 | - | - | - | |
| Exposure Limits | - | - | - | |
| Exposure Routes | Public | No unacceptable risks to bystanders identified | ||
| Occupational | No unacceptable risks to operators or other workers identified | |||
| Examples of European MRLs (mg kg-1) | Value | Apricots, nectarines, peaches, barley grains and oat grain: 0.2; Vegetables, other fruit and other cereal grains: 0.05 | ||
| Note | Current May 2007. For the EU pesticides database click here |
|||
| Drinking Water MAC (µg l-1) | - | - | - | |
Health issues:
| Carcinogen | Mutagen | Endocrine disrupter | Reproduction / development effects | Acetyl cholinesterase inhibitor | Neurotoxicant | Respiratory tract irritant | Skin irritant | Eye irritant |
|
- |
- |
- |
- |
- |
|
|
|
| General human health issues | No further information available | |||||||
: Yes, known to cause a problem
: No, known not to cause a problem
: Possibly, status not identified
- : No data
Handling issues:
| Language | Name |
| English | propiconazole |
| French | propiconazol |
| German | Propiconazol |
| Danish | propiconazol |
| Italian | propiconazolo |
| Spanish | propiconazol |
| Greek | - |
| Slovenian | propiokonazol |
| Polish | propikonazol |
| Swedish | propikonazol |
| Hungarian | propikonazol |
| Dutch | propiconazool |
| Record last updated: Friday 07 June 2013 Contact: aeru@herts.ac.uk © Copyright University of Hertfordshire |